• Immuno-Oncology: Tumor Mutations – Los Angeles, CA

    Samuel Oschin Cancer Center and Comprehensive Cancer Institute 8700 Beverly Blvd, Los Angeles, CA, United States

    This initiative is designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses and other healthcare professionals and teams involved in the management of patients with cancer who are treated or eligible for treatment with immunotherapy.

  • CRC Grand Rounds – New York, NY

    Lenox Hill Hospital/Northwell Health 100 E 77th Street, New York, NY, United States

    This live activity will cover the treatment and management of patients with metastatic colorectal cancer.

  • IPF GR 2019 – Victoria, TX

    Citizens Medical Center 2701 Hospital Drive, Victoria, TX, United States

    This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with IPF.

  • IPF GR 2019 – Brooklyn, NY

    The Brooklyn Hospital Center 121 DeKalb Avenue, Brooklyn, NY, United States

    This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with IPF.

  • THRIVE: A Spotlight on Hypoglycemia – Northfield, MN

    Northfield Hospital and Clinics 2000 North Ave, Northfield, MN, United States

    This educational activity is intended for primary care physicians, physician assistants, nurse practitioners, pharmacists, certified diabetes educators and other HCPs who care for patients with diabetes.

  • Hemophilia A EHL – Miami, FL

    Keiser University 2101 NW 117th Ave, Miami, FL, United States

    This initiative is designed to meet the educational needs of hematologists who treat patients with hemophilia A.

  • Hem Malignancies: AML/CLL – Bronx, NY

    Montefiore Medical Center 111 East 210th Street, Bronx, NY, United States

    This activity is designed to meet the needs of US-based hematologists, medical oncologists, oncology nurses, and other healthcare providers involved in the treatment of AML and CLL.